4
Changes in Ownership
Harmony Biosciences Holdings, Inc. Filed Acc 0001104659-22-071014
President, CEO sold 25,000 shares at an average $44.18 ($1,104,411)
- President, CEO acquired 25,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Jacobs John C President, CEO | 2022-06-13 | Option exercise | +25,000 | $8.22 | $205,500 | 25,000 | D: show line 1 in the form |
| Jacobs John C President, CEO | 2022-06-13 | Sale | −9,803 | $43.63 | $427,735 | 15,197 | D: show line 2 in the form |
| Jacobs John C President, CEO | 2022-06-13 | Sale | −15,197 | $44.53 | $676,675 | 0 | D: show line 3 in the form |
| Open-market sales · 25,000 sh · avg $44.18 · $1,104,411 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Jacobs John C President, CEO | 2022-06-13 | Option exercise · Stock Option | −25,000 | 169,751 | D: show line 4 in the form |
Loading xslF345X03/tm2218405-1_4seq1.xml…